Effects of High-Dose Oral Insulin on Immune Responses in Children at High Risk for Type 1 Diabetes
Ezio Bonifacio(Technische Universität Dresden), Peter Achenbach(TUM Klinikum), Florian Buettner(Helmholtz Zentrum München), Karin Lange(Medizinische Hochschule Hannover), Marietta Rottenkolber(Zimmer Biomet (Germany)), Georgeanna J. Klingensmith(University of Colorado Denver), Anne Eugster(TU Dresden), Claudia Peplow(TUM Klinikum), Joerg Hasford(Ludwig-Maximilians-Universität München), Anke Theil(Technische Universität Dresden), Polly J. Bingley(University of Bristol), Ramona Puff(TUM Klinikum), Anette‐G. Ziegler(TUM Klinikum), Edith Schober(Medical University of Vienna)
Cited by 196
Related Papers
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
A New Prognostic Score for Survival of Patients With Chronic Myeloid Leukemia Treated With Interferon Alfa Writing Committee for the Collaborative CML Prognostic Factors Project Group
|JNCI Journal of the National Cancer Institute|1998|820
Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)
|Journal of Clinical Oncology|2005|573